NNovo Nordisk Read More Novo Nordisk’s Oral Wegovy Nod Lifts Shares, but the Valuation Debate Rages On2026-07-16 Novo Nordisk added another chapter to its recovery story on Wednesday, when European regulators approved the first oral…